Wolfram syndrome: Portuguese research.

Autor: Ferreras C; Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal. cristinaferreras87@gmail.com.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal. cristinaferreras87@gmail.com., Gorito V; Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal., Pedro J; Department of Endocrinology, Centro Hospitalar São João, Porto, Portugal., Ferreira S; Pediatric Endocrinology and Diabetology Unit, Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal., Costa C; Pediatric Endocrinology and Diabetology Unit, Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal., Santos Silva R; Pediatric Endocrinology and Diabetology Unit, Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal., Castro Correia C; Pediatric Endocrinology and Diabetology Unit, Department of Paediatrics, Centro Hospitalar São João, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal, Portugal.
Jazyk: angličtina
Zdroj: Endokrynologia Polska [Endokrynol Pol] 2021; Vol. 72 (4), pp. 353-356. Date of Electronic Publication: 2021 May 19.
DOI: 10.5603/EP.a2021.0038
Abstrakt: Introduction: Wolfram syndrome (WFS) is a neurological and endocrinological degenerative disorder, also known as DIDMOAD (Diabetes Insipidus, early-onset Diabetes Mellitus, progressive Optic Atrophy, and Deafness) syndrome. It is an autosomal recessive disorder, mostly involving the Wolfram syndrome 1 gene (WFS1). The phenotypic pleiomorphism, rarity, and molecular complexity complicate the follow-up of these patients.
Material and Methods: We aimed to describe the clinical characteristics and the follow-up of 11 patients with this disorder. We retrospectively analysed all WFS patients diagnosed between 1990 and 2020 in the Centro Hospitalar São João, a tertiary hospital in Northern Portugal.
Results: Eleven patients were included. Four patients had all 4 components of DIDMOAD. The presentation was diabetes mellitus (DM) in 9 patients, optic atrophy (OA) in another patient, and diabetes insipidus (DI) in another one. The median age of DM and OA diagnosis was 6 and 14 years, respectively. Nine patients had diabetes mellitus, and the other 2 patients had impaired glucose tolerance. All patients had OA. Four patients presented DI, all of them diagnosed in adolescence. Four patients had hearing impairment, 5 had urological abnormalities, 5 had neurological disorders, and 8 had psychiatry disorders. Eight patients had a broad spectrum of recessive mutations in WFS1.
Conclusion: The information obtained in this study can facilitate further research in an attempt to improve prevention strategies for this devastating disease.
Databáze: MEDLINE